Daniel Griffith Anderson Sigilon Therapeutics, Inc. (SGTX) insider trading activity
Daniel Griffith Anderson is of Sigilon Therapeutics, Inc.. Currently has a direct ownership of 2.02 Million shares of SGTX, which is worth approximately $0. The most recent transaction as insider was on Jun 02, 2021, when has been sold 200,000 shares (Common Stock) at a price of $10.0 per share, resulting in proceeds of $2,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
2.02M
0%
3M change
0%
12M change
Total Value Held
$0
DGA
Daniel Griffith Anderson
Cambridge, MA